CIATRIX Trademark
Trademark Overview
On Thursday, March 7, 2024, a trademark application was filed for CIATRIX with the United States Patent and Trademark Office. The USPTO has given the CIATRIX trademark a serial number of 98439171. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 1, 2025. This trademark is owned by CIATRIX, Inc.. The CIATRIX trademark is filed in the Medical Instrument Products category with the following description:
medical devices for use in treating neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; therapeutic devices using cerebrospinal fluid motion, cerebrospinal fluid pressure changes, spinal motion, and respiratory inhalation and exhalation to improve performance of lymphatic system, performance of glymphatic system, posture, glymphatic clearance, drug delivery in cerebrospinal fluid, and drug delivery in blood and to lower brain wave activity to provide relief from neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; diagnostic devices, namely, medical diagnostic apparatus for testing cerebrospinal fluid dynamics
General Information
| Serial Number | 98439171 |
| Word Mark | CIATRIX |
| Filing Date | Thursday, March 7, 2024 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, April 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 4, 2025 |
Trademark Statements
| Goods and Services | medical devices for use in treating neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; therapeutic devices using cerebrospinal fluid motion, cerebrospinal fluid pressure changes, spinal motion, and respiratory inhalation and exhalation to improve performance of lymphatic system, performance of glymphatic system, posture, glymphatic clearance, drug delivery in cerebrospinal fluid, and drug delivery in blood and to lower brain wave activity to provide relief from neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; diagnostic devices, namely, medical diagnostic apparatus for testing cerebrospinal fluid dynamics |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 7, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CIATRIX, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | LEWES, DE 19958 |
| Party Name | CIATRIX, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | LEWES, DE 19958 |
Trademark Events
| Event Date | Event Description |
| Thursday, March 7, 2024 | NEW APPLICATION ENTERED |
| Monday, July 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, September 20, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, October 1, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 1, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, January 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 13, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, January 13, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Monday, January 13, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, January 13, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 29, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 4, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 4, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 1, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, January 13, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
